Autoimmunity Reviews

Papers
(The H4-Index of Autoimmunity Reviews is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Editorial Board195
Editorial Board155
Comment on “Meta-analysis of meteorological conditions and rheumatoid arthritis”128
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence119
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective114
Susac syndrome: A scoping review107
Autoantibody internalization in myositis skeletal muscle: Emerging evidence, mechanistic insights, and therapeutic relevance100
MTHFR polymorphisms in autoimmune diseases: Mechanistic and clinical perspectives100
The Trm-Treg Axis as a tissue-encoded immune checkpoint in chronic inflammation and autoimmunity99
The BAFF/APRIL system at the crossroads of B cell memory and autoimmune relapse: Implication into the therapeutic strategies93
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch90
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016–2022)85
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review84
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders82
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases79
Endometriosis and autoimmunity76
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis71
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis68
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination64
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate63
Seronegative autoimmune diseases: A challenging diagnosis63
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes63
Metabolic traits of T cells and the implications in autoimmune diseases62
Psychiatric manifestations of autoimmune encephalitis57
Editorial Board57
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases56
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered56
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease55
Autoimmunity, diet and autophagy53
Autoimmune pre-disease53
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases53
STING-inflammasome axis in autoimmune diseases and inflammation-related disease52
Idiopathic pericarditis in 2025: Advances in diagnosis and therapeutic strategies52
Corrigendum to “Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis” [Autoimmunity Reviews Volume 2451
Can anticoagulation be withdrawn in APS patients after aPL negativization?51
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy50
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.49
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 202149
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature47
The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction46
Understanding the effects of Janus kinase inhibitors on the cardiovascular system in comparison to main biological DMARDs in rheumatoid arthritis45
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy45
Dysregulation of helper, regulatory, and follicular CD4+ T cells in primary antiphospholipid syndrome: Immunopathology and implications for targeted immunomodulatory therapy45
0.1846079826355